Ningbo Vitax Biotech

Ningbo Vitax Biotech is a biotechnology company based in China that specializes in the development and manufacture of core raw materials for the in vitro diagnostics (IVD) industry. The company's primary focus is on producing high-purity recombinant antigens and monoclonal antibodies used in various diagnostic platforms, including lateral flow assays, ELISA, and chemiluminescence. Their product portfolio covers a broad spectrum of clinical areas such as infectious diseases, tumor markers, cardiac markers, and inflammation. In addition to catalog products, Vitax Biotech provides contract services for protein expression and antibody discovery to support global diagnostic manufacturers. The company is recognized for its rapid response in developing reagents for emerging pathogens, such as SARS-CoV-2 and various influenza strains.